Showing 17 of 17 recruiting trials for “Retinopathy of prematurity”
RecruitingNCT06612541 ↗
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Pain and Comfort in the Examination of Retinopathy of Prematurity
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
RecruitingNCT05558059 ↗
Imaging Retinal Vasculature in Infant Eyes
RecruitingNCT06315556 ↗
An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)
The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination
Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
RecruitingNCT06265363 ↗
Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants with a BW >1500 Grs or GA ≥33 Wks in Turkey.
RecruitingNCT05705258 ↗
A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)
Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants
👨⚕️ Hanna Maria Öhnell, PhD, Ophthalmology, dep. of clinical sciences Lund, Lund University, Skåne University Hospital, Sweden📍 2 sites📅 Started Jun 2022View details ↗
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
RecruitingNCT04939571 ↗
European Disease Registry on Retinopathy of Prematurity (ROP)
👨⚕️ Andreas Stahl, Professor, Department of Ophthalmology, University Medicine Greifswald📍 59 sites📅 Started Aug 2021View details ↗
RecruitingNCT04819893 ↗
Study of the Involvement of Fatty Acids in Retinopathy of Prematurity: Relationship Between Retinopathy of Prematurity and the Rate of Expression of Transplacental Fatty Acid Receptors.
Enrolling by InvitationNCT03076697 ↗
Smartphone Screening for Eye Diseases
RecruitingNCT04420156 ↗
Clinical and Genetic Analysis of ROP
👨⚕️ John P Campbell, M.D., Oregon Health and Science University📍 5 sites📅 Started Jul 2011View details ↗
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
👨⚕️ Maria Martínez-Castellanos, MD, Asociación para Evitar la Ceguera en México📍 1 site📅 Started Jul 2007View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →